Europe Wants to Measure Drug-Driving. But Can Countries Compare Their Results?
Trendline shows why different saliva tests, cut-offs and drug panels make European drug-driving data difficult to compare—and where Drug Hunter fits.
-
-
Europe’s Cocaine Map Is Changing. Are Testing Strategies Changing with It?
EUDA wastewater data shows cocaine levels rising across European cities. The trend is not only growing – it is spreading. What does this changing geography mean for monitoring and on-site testing?
-
From Breath to Saliva: Is Evidential Drug Testing Moving to the Roadside?
The UK is reconsidering how drug-driving evidence is collected. With blood-test results sometimes taking months, could quantitative saliva analysis move more of the forensic process directly to the roadside?
-
Positive at the Roadside, Below the Limit in Blood: Why Drug-Test Results Diverge
A positive roadside drug test can lead to blood collection, laboratory analysis and legal procedures—only for the final result to fall below the applicable threshold. The reason is not always a faulty test. Timing, cut-offs, metabolites and national law all shape what a “positive” result actually means.
-
Recent Drug Use vs. Residual Traces: What Quantitative Saliva Testing Can Tell Us
A positive saliva drug test proves that a test reacted. It does not always explain when the drug was used, how much is present, or whether the result exceeds the applicable legal threshold.
-
GHB Detection Beyond the Laboratory: Why Quantitative Saliva Analysis Matters
Professionals need to understand how much GHB is present, whether the measured concentration may indicate exposure, and whether the result can support further medical, safety, or investigative decisions.
That is why quantitative GHB detection matters. -
Drug Hunter to Exhibit at Forensics Europe Expo 2026 in London
Meet Drug Hunter by SafePAS at Forensics Europe Expo 2026, stand FE-T65, and discover on-site saliva drug testing for law enforcement and public safety teams.
-
Germany After Cannabis Legalisation: Why Roadside Drug Testing Must Move Beyond False Positives
Germany has changed its cannabis laws and introduced a new THC driving limit. But many roadside drug tests still operate like binary screening tools, creating a risk of false-positive preselection, unnecessary blood tests, and wasted police and laboratory capacity. The next step is not just faster testing — it is more informative on-site drug testing….
-
SafePAS to Showcase Breakthrough Drug Detection Technology at GPEC 2026
SafePAS is proud to participate in the upcoming General Police Equipment Exhibition & Conference (GPEC) in Leipzig, Germany, from May 20–22, 2026. As Europe’s premier closed event for internal security and law enforcement, GPEC serves as a critical platform for us to engage with decision-makers, practitioners, and technology innovators. At this year’s event, we will…
-
Drug Use Trends in 2026: Why Modern Drug Detection Must Evolve
Explore drug use trends in 2026 across Europe, the US, and Australia. Learn why synthetic drugs and polysubstance use demand new detection technologies like Drug Hunter.
